Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review

Please use this link to access this publication. Abstract Anecdotal references, preclinical, and non-randomized studies support the therapeutic potential of cannabinoids for movement disorders (MD).

March 14, 2024

Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy

Abstract OBJECTIVE To assess the effect of oral cannabidiol (CBD) administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with idiopathic epilepsy.

January 11, 2024

Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws

Key Points Question  Is the legalization of recreational cannabis in the US associated with changes in cannabis use outcomes and cannabis use disorder across racial and

October 7, 2024

Quarterly trends in past-month cannabis use in the United States, 2015-2019

Please use this link to access this publication. Abstract Background Prevalence of cannabis use has been increasing among select subgroups in the US; however, trend

May 17, 2025

Quantification of Cannabis in Infused Consumer Products and Their Residues on Skin

Please use this link to access this publication. Abstract Cannabis consumer products are a $4.6 billion industry in the U.S. that is projected to exceed $14

December 17, 2024

Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy

Please follow this link to access this publication: https://www.sciencedirect.com/science/article/abs/pii/S1525505019301167 Abstract Treatment-resistant epilepsy (TRE) is associated with low quality of life (QOL). Cannabidiol (CBD) may improve

November 15, 2023

Qualifying Conditions Of Medical Cannabis License Holders In The United States

Abstract The evidence for cannabis’s treatment efficacy across different conditions varies widely, and comprehensive data on the conditions for which people use cannabis are lacking.

August 1, 2024

Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report

Please use this link to access this publication. Abstract Objectives Anecdotal reports and preliminary studies suggest a therapeutic potential of cannabis in Tourette syndrome. We

Pulmonary effects of inhaled cannabis smoke

Please use this link to access this publication. ABSTRACT Background: The smoke generated from cannabis delivers biologically active cannabinoids and a number of combustion-derived toxins, both

Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates

ABSTRACT Background Cannabis is one of the most widely used substances worldwide. Heavy use is associated with an increased risk of cannabis use disorders, psychotic

October 7, 2024